Bank of New York Mellon’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.7K | Hold |
26,482
| – | – | ﹤0.01% | 4046 |
|
|
2025
Q1 | $93.7K | Hold |
26,482
| – | – | ﹤0.01% | 3989 |
|
|
2024
Q4 | $84.5K | Hold |
26,482
| – | – | ﹤0.01% | 4020 |
|
|
2024
Q3 | $97.2K | Hold |
26,482
| – | – | ﹤0.01% | 3997 |
|
|
2024
Q2 | $124K | Hold |
26,482
| – | – | ﹤0.01% | 4004 |
|
|
2024
Q1 | $233K | Buy |
26,482
+1
| +0% | +$9 | ﹤0.01% | 3879 |
|
|
2023
Q4 | $113K | Hold |
26,481
| – | – | ﹤0.01% | 4060 |
|
|
2023
Q3 | $90.3K | Buy |
26,481
+1
| +0% | +$3 | ﹤0.01% | 4085 |
|
|
2023
Q2 | $149K | Hold |
26,480
| – | – | ﹤0.01% | 4025 |
|
|
2023
Q1 | $128K | Hold |
26,480
| – | – | ﹤0.01% | 4028 |
|
|
2022
Q4 | $160K | Hold |
26,480
| – | – | ﹤0.01% | 4030 |
|
|
2022
Q3 | $127K | Hold |
26,480
| – | – | ﹤0.01% | 4152 |
|
|
2022
Q2 | $151K | Sell |
26,480
-285
| -1% | -$1.63K | ﹤0.01% | 4143 |
|
|
2022
Q1 | $191K | Hold |
26,765
| – | – | ﹤0.01% | 4257 |
|
|
2021
Q4 | $213K | Hold |
26,765
| – | – | ﹤0.01% | 4253 |
|
|
2021
Q3 | $299K | Hold |
26,765
| – | – | ﹤0.01% | 4034 |
|
|
2021
Q2 | $391K | Buy |
26,765
+14,990
| +127% | +$219K | ﹤0.01% | 3883 |
|
|
2021
Q1 | $213K | Buy |
+11,775
| New | +$213K | ﹤0.01% | 4029 |
|